Long-term administration of angiotension-converting enzyme inhibitor improves the outcome of chronic heart failure in senile patients.
- Author:
Xuelin CHEN
1
;
Jinnong ZHANG
;
Qinmei KE
;
Yinhuan ZHANG
;
Chengyun LIU
Author Information
1. Geriatric Department, Xiehe Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022.
- Publication Type:Journal Article
- MeSH:
Aged;
Angiotensin-Converting Enzyme Inhibitors;
administration & dosage;
Chronic Disease;
Female;
Heart Failure;
drug therapy;
etiology;
Humans;
Hypertension;
complications;
Male;
Myocardial Ischemia;
complications;
Retrospective Studies;
Treatment Outcome
- From:
Journal of Huazhong University of Science and Technology (Medical Sciences)
2002;22(3):257-259
- CountryChina
- Language:English
-
Abstract:
One hundred and sixteen senile patients (older than 65 years) with chronic heart failure (CHF) were analyzed retrospectively in order to verify if old patients with CHF would benefit from long-term (one year) angiotension-converting enzyme inhibitor (ACEI) treatment. The frequency of drugs (including ACEI, digitalis and diuretic) used was stratified into four degrees accordingly. Development of the CHF was scored with regard to relapse rate and severity of this disease. Stepwise regression analysis was applied to explore the relationship between the scored outcome of CHF and the frequency of individual drug administration. A significant relationship of the scored outcome of CHF to the frequency of ACEI usage but not to digitalis nor to diuretics was found (partial coefficient of the correlation r = 0.42, P = 0.002). It was concluded that the long-term administration of ACEI improves the outcome of CHF in senile patients.
